Table 5 Acaricides with proven preventive efficacy against Babesia spp. transmission by D. reticulatus and R. sanguineus ticks in dogs
From: A review of canine babesiosis: the European perspective
Principle active (Brand name, presentation - company) | Percentage of protection of B. canis infection (time period of evaluation) | Acaricide efficacy against D. reticulatus in % (time period of evaluation) | Reference |
|---|---|---|---|
Afoxolaner (NexGard®, chewable tablets - MERIAL) | 100 (56 days) | 99 (4 weeks) | [173] |
Fipronil + Permethrin (Frontline Tri-Act®, Spot on - MERIAL) | 94.3 (4 weeks) | 98.3 (28 days) | [174] |
Fluralaner (Bravecto®, chewable tablets - MSD) | 100 (12 weeks) | 99.2 (86 days) | [175] |
Flumethrin + Imidacloprid (Seresto® Collar - BAYER) | 100 (4 weeks) | 96.0 (48 h), 100 (4 days) | [176] |
Percentage of protection of B. vogeli infection (time period of evaluation) | Acaricide efficacy against R. sanguineus in % (time period of evaluation) | ||
Flumethrin + Imidacloprid (Seresto® Collar - BAYER) | 100 (1 year) | 99.7 (48 h) | [177] |
Imidacloprid + Permethrin (Advantix®, spot on - BAYER) | 88.3–94.4 % (12 months)a | 95–100 |